Dopamine receptor availability in Tourette's syndrome

Psychiatry Research: Neuroimaging

Volumn 55, Issue 4, 1994, Pages 193-203

  George, Mark S ^a   Robertson, Mary M ^b   Costa, Durval C ^c   Ell, Peter J ^c   Trimble, Michael R ^d   Pilowsky, Lyn ^e   Verhoeff, N P L G ^f  

^a National Institutes of Health Library   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

123iodo 6 methoxybenzamide; neuroleptics; Single photon emission computed tomography; tics

Indexed keywords

CLOMIPRAMINE; DOPAMINE RECEPTOR; FLUPENTIXOL; HALOPERIDOL; PIMOZIDE; SULPIRIDE;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BASAL GANGLIA; CHILD; COMPARATIVE STUDY; FEMALE; FRONTAL LOBE; HUMAN; MALE; MIDDLE AGE; RECEPTORS, DOPAMINE D2; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOURETTE SYNDROME; VISUAL CORTEX;

EID: 0028566851     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-4927(94)90014-0     Document Type: Article

References (37)

1. Brain imaging as a tool in establishing a theory of brain pathology in obsessive compulsive disorder
2. Functional neuroanatomy of Tourette's Syndrome studied with FDG PET
3. 2 receptor imaging with SPET: Studies in different neuropsychiatric disorders
4. Gilles de la Tourette's Syndrome An overview of clinical experience
5. Gilles de la Tourette's Syndrome: A review of clinical and research studies and consideration of future directions for investigation
6. Tourette Syndrome in Monroe County school children
7. Gilles de la Tourette Syndrome: Studies with the fluorine-18-labelled fluorodeoxyglucose positron emission tomographic method
8. Structural and functional studies of Gilles de la Tourette Syndrome
9. Pimozide: Use in Tourette's Syndrome
10. 123I in humans
11. Nuclear magnetic resonance study of obsessive-compulsive disorder
12. 1, dopamine receptor
13. Toward a psychopharmacologic neuroanatomy of obsessive-compulsive disorder
14. Elevated frontal cerebral blood flow in Gilles de la Tourette Syndrome (GTS): A 99Tcm-HMPAO study
15. Psychologic and neuropsychologic aspects of Tourette's Syndrome
16. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's Syndrome
17. Brain MRI in obsessive-compulsive disorder
18. In vivo SPECT imaging of CNS D-2 dopamine receptors: Initial studies with iodine-123-IBZM in humans
19. 123I]IBZM: A potential CNS D-2 dopamine receptor imaging agent
20. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity
21. Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative x-ray computed tomography
22. Dopamine competes for 123 I-IBZM binding in vivo
23. Cerebral glucose metabolic rates in obsessive-compulsive disorder
24. Gilles de la Tourette Syndrome and obsesive-compulsive disorder: Evidence supporting a genetic-relationship
25. Reduced basal ganglia volumes in Tourette's Syndrome using three-dimensional reconstruction techniques from magnetic resonance images
26. The Gilles de la Tourette Syndrome: The current status
27. Management of Gilles de la Tourette Syndrome using sulpiride
28. The psychopathology of the Gilles de la Tourette Syndrome
29. Acquired Tourettism in adult life
30. An update on Tourette's Syndrome
31. Abnormal dopamine uptake sites in postmortem striatal specimens from patients with Tourette Syndrome
32. Volumetric MRI changes in basal ganglia of children with Tourette's Syndrome
33. Positron emission tomography evaluation of dopamine D-2 receptors in adults with Tourette Syndrome
34. Distribution of brain dysfunction in Tourette Syndrome revealed by PET scanning
35. Cerebral glucose metabolism in childhood onset obsessive compulsive disorder